SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-24-049534
Filing Date
2024-12-13
Accepted
2024-12-13 16:46:18
Documents
14
Period of Report
2024-12-10
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20039952_8k.htm   iXBRL 8-K 33746
2 EXHIBIT 3.1 ef20039952_ex3-1.htm EX-3.1 146941
  Complete submission text file 0001140361-24-049534.txt   356834

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA siga-20241210.xsd EX-101.SCH 3971
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE siga-20241210_lab.xml EX-101.LAB 22692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE siga-20241210_pre.xml EX-101.PRE 16545
16 EXTRACTED XBRL INSTANCE DOCUMENT ef20039952_8k_htm.xml XML 4213
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

IRS No.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38436 | Film No.: 241549062
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)